These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 25791050)
1. [Possibilities of modern imaging technologies in early diagnosis of Alzheimer disease]. Unschuld PG Ther Umsch; 2015 Apr; 72(4):261-9. PubMed ID: 25791050 [TBL] [Abstract][Full Text] [Related]
2. Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities. Parent MJ; Zimmer ER; Shin M; Kang MS; Fonov VS; Mathieu A; Aliaga A; Kostikov A; Do Carmo S; Dea D; Poirier J; Soucy JP; Gauthier S; Cuello AC; Rosa-Neto P J Neurosci; 2017 Dec; 37(50):12263-12271. PubMed ID: 29097597 [TBL] [Abstract][Full Text] [Related]
3. [Novel neuroimaging perspectives in the diagnosis of dementia]. Jessen F Nervenarzt; 2008 Nov; 79 Suppl 3():129-36; quiz 137. PubMed ID: 18830576 [TBL] [Abstract][Full Text] [Related]
4. [Brain imaging of Alzheimer' disease: state of the art and perspectives for clinicians]. Trombella S; Assal F; Zekry D; Gold G; Giannakopoulos P; Garibotto V; Démonet JF; Frisoni GB Rev Med Suisse; 2016 Apr; 12(515):795-8. PubMed ID: 27276723 [TBL] [Abstract][Full Text] [Related]
5. Multimodal Discrimination of Alzheimer's Disease Based on Regional Cortical Atrophy and Hypometabolism. Yun HJ; Kwak K; Lee JM; PLoS One; 2015; 10(6):e0129250. PubMed ID: 26061669 [TBL] [Abstract][Full Text] [Related]
6. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia. Trzepacz PT; Yu P; Sun J; Schuh K; Case M; Witte MM; Hochstetler H; Hake A; Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175 [TBL] [Abstract][Full Text] [Related]
7. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum. Tosun D; Schuff N; Jagust W; Weiner MW; Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336 [TBL] [Abstract][Full Text] [Related]
8. Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease. Ota K; Oishi N; Ito K; Fukuyama H; ; J Neurosci Methods; 2015 Dec; 256():168-83. PubMed ID: 26318777 [TBL] [Abstract][Full Text] [Related]
9. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B. Leinonen V; Alafuzoff I; Aalto S; Suotunen T; Savolainen S; Någren K; Tapiola T; Pirttilä T; Rinne J; Jääskeläinen JE; Soininen H; Rinne JO Arch Neurol; 2008 Oct; 65(10):1304-9. PubMed ID: 18695050 [TBL] [Abstract][Full Text] [Related]
13. Prefrontal hypometabolism in Alzheimer disease is related to longitudinal amyloid accumulation in remote brain regions. Klupp E; Grimmer T; Tahmasian M; Sorg C; Yakushev I; Yousefi BH; Drzezga A; Förster S J Nucl Med; 2015 Mar; 56(3):399-404. PubMed ID: 25678488 [TBL] [Abstract][Full Text] [Related]
14. [Imaging diagnosis of Alzheimer's disease]. Mänz C; Reimold M; Bender B; Bares R; Ernemann U; Horger M Rofo; 2012 Dec; 184(12):1079-82. PubMed ID: 23212812 [No Abstract] [Full Text] [Related]
15. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG. Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246 [TBL] [Abstract][Full Text] [Related]